NanoSpectrometer Biomarker Discovery and Confirmation Study
This study will evaluate exhaled volatile organic compounds (VOC's) in the breath of participants with stage 1 lung cancer, their house-mates, and matched controls. The goal of the study is to identify VOC fingerprints that are only detectable in those with stage 1 lung cancer.
Checked against the public recordLast updated Jul 22, 2020 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- Johns Hopkins University
- Interventions being studied
- Diagnostic Test: Breath Analysis
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Adults age 18 and over with diagnosed Stage 1 Lung Cancer (cases) * Adults age 18 and over without Lung cancer (type 1 controls) * Adults age 18 and over who live in the same environment as the cases (type 2 controls) Exclusion Criteria N/A
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Johns Hopkins HospitalBaltimore, Maryland
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jul 22, 2020. Always confirm current availability with the study team.